Novo Nordisk Expands Wegovy Access

This is a news story, published by CNBC, that relates primarily to Novo Nordisk news.

Novo Nordisk news

For more Novo Nordisk news, you can click here:

more Novo Nordisk news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

weight loss drug Wegovy

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Novo Nordisk spokesperson news, Novo news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Novo Nordisk

CNBC

•

Health

Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 40%

Summary

Nutrition label

79% Informative

Novo Nordisk says it will offer its weight loss drug Wegovy through telehealth providers Hims & Hers Health , Ro and Life MD.

The Danish drugmaker is racing to capture more patients now that many compounding pharmacies are legally restricted from making cheaper, unapproved versions of the drug.

Hems & Hers shares soared 40% in premarket trading Tuesday .

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech